Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3357 results

Sort By:

Evaluating a Standardized Checklist Bundle for Optimizing Procedural Ergonomics in Endoscopy

Study ID: NCT06195631
Start Date: 2025-04
End Date: 2026-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Standardized Checklist for Optimizing Procedural Ergonomics in Endoscopy (SCOPE- E) Bundle

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Study ID: NCT06529822
Start Date: 2025-02-28
End Date: 2033-08-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

16

Intervention / Treatment

Synthetic long peptide personalized cancer vaccine

Poly ICLC

Signatera assay

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT06568939
Start Date: 2025-01-30
End Date: 2028-02-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Telisoruzumab vedoctin

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

Impact of Anatomy-Based Cochlear Implant Programming on Early Performance

Study ID: NCT06734039
Start Date: 2025-04-30
End Date: 2028-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Programming of cochlear implant audio processor frequency settings

Sponsor

Med-El Corporation

Source: clinicaltrials.gov

Share:
Add to list

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Study ID: NCT06709339
Start Date: 2025-04
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

120

Intervention / Treatment

Faricimab Injection [Vabysmo]

Sponsor

Association for Innovation and Biomedical Research on Light and Image

Source: clinicaltrials.gov

Share:
Add to list

HS-10502 Combination Treatment in Patients with Advanced Solid Tumors

Study ID: NCT06769425
Start Date: 2025-02-28
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

154

Intervention / Treatment

HS-10502 + NHA

HS-10502 + HS-20093

HS-10502+ Apatinib

HS-10502 + HS-20089

HS-10502 + Platinum + Bevacizumab

HS-10502 + nab-paclitaxel or Docetaxel or Irinotecan

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Artificial Intelligence Delivered Cardiac Magnetic Resonance - Prospective Validation

Study ID: NCT06061822
Start Date: 2025-03-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

AI-assisted cardiac magnetic resonance imaging

Sponsor

Imperial College London

Source: clinicaltrials.gov

Share:
Add to list

Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure

Study ID: NCT06780722
Start Date: 2025-06-01
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

blood sampling

Sponsor

Nantes University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Enhanced Problem-solving Therapy and HIV Engagement Support to Improve Perinatal Mental Health & HIV Outcomes in Malawi

Study ID: NCT06702722
Start Date: 2025-02
End Date: 2028-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Enhanced Friendship Bench

Enhanced usual care

Sponsor

University of North Carolina, Chapel Hill

Source: clinicaltrials.gov

Share:
Add to list

Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation

Study ID: NCT06637839
Start Date: 2025-04
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

131

Intervention / Treatment

Moderate-Intensity Locomotor Training Program

High-Intensity Locomotor Training Program

High-Step Count Locomotor Training Program

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list